retatrutide benefits clinical trial retatrutide (“reta”) is an experimental weight-loss drug currently in Phase 3 trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Retatrutide Subcutaneous Fat Loss Results:

If LifeRxs flat pricing and strong credentials match what youre looking for, start with a consultation to see if its the right fit for your weight-loss goals

Baseline Cardiovascular Assessment Before initiating therapy, clinicians should obtain a comprehensive cardiovascular history, including previous cardiac events, arrhythmias, hypertension, and family history of premature cardiovascular disease

On average, 1 in 2 users paused or stopped their medication within the first 4 months

The TRIUMPH-4 Phase 3 trial confirmed this: at 68 weeks, mean weight loss had reached 28.7% at 12 mg, an additional 4.5 percentage points beyond the 48-week Phase 2 result

Be fully open about your medication status during your consultation so your team can plan safely around it